Cochlear Americas13059 E Peakview Avecentennial Co 80111 Pma Numberp890027 Supplement Numbers062 Date Received04 26 2022 Decision Date10 31 2022 Product Code Mcm Advisory Committee Ear Nose Throat Supplement Typenormal 180 Day Track Supplement Reason Change Design Components Specifications Material Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Cochlear Americas13059 E Peakview Avecentennial Co 80111 Pma Numberp890027 Supplement Numbers062 Date Received04 26 2022 Decision Date10 31 2022 Product Code Mcm Advisory Committee Ear Nose Throat Supplement Typenormal 180 Day Track Supplement Reason Change Design Components Specifications Material Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P890027S062 Cochlear Americas13059 E Peakview Avecentennial, CO 80111 PMA NumberP890027 Supplement NumberS062 Date Received04/26/2022 Decision Date10/31/2022 Product Code MCM  Advisory Committee Ear Nose & Throat Supplement Typenormal 180 Day Track Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No	Nucleus Cochlear Implant Systems	2022-10-31